Medtronic (MDT) Net Cash Flow (2014 - 2026)

Medtronic (MDT) has 13 years of Net Cash Flow data on file, last reported at $768.0 million in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 10.5% year-over-year to $768.0 million; the trailing twelve-month figure through Apr 2026 stood at -$355.0 million (down 147.59% YoY), and the FY2026 full-year result was -$355.0 million, down 147.59% from the prior year.
• Net Cash Flow grew to $768.0 million in Q2 2026, from -$159.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 to a low of -$2.9 billion in Q2 2023.
• A 5-year average of -$58.8 million and a median of $22.0 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow soared 3036.84% in 2022 and sank 25200.0% in 2025, its largest moves.
• Tracing MDT's Net Cash Flow over 5 years: stood at $2.8 billion in 2022, then sank by 94.73% to $147.0 million in 2023, then tumbled by 46.26% to $79.0 million in 2024, then tumbled by 39.24% to $48.0 million in 2025, then jumped by 1500.0% to $768.0 million in 2026.
• Business Quant data shows MDT's Net Cash Flow at $768.0 million in Q2 2026, -$159.0 million in Q1 2026, and $48.0 million in Q4 2025.